Description
ONCOTYPE DX INVASIVE BREAST CANCER ASSAY
First action · last action
2012-02-07 · 2012-02-07
Transactions
1
First transaction's obligation
$4,175
Base + all options value (sum of deltas)
$4,175
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-02-07+$4,175= $4,175
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-02-07 | +$4,175 | $4,175 | ONCOTYPE DX INVASIVE BREAST CANCER ASSAY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RHN3L7SBF7J6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0377 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $55,912 | FY2026 |
| 36C26225N0452 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $114,305 | FY2025 |
| 36C26224N0385 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $114,305 | FY2024 |
| 36C26223P1608 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $10,362 | FY2023 |
| 36C26223N0393 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $194,070 | FY2023 |
| 36C26223A0031 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2023 |
Other recipients under Q301 from 249-NETWORK CONTRACT OFFICE 9 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24914J0003 | TOSOH BIOSCIENCE, INC. | 249-NETWORK CONTRACT OFFICE 9 | $20,781 | FY2014 |
| VA24912F1831 | ORTHO-CLINICAL DIAGNOSTICS INC | 249-NETWORK CONTRACT OFFICE 9 | $18,008 | FY2012 |
| VA24912P1308 | GENETIC ASSAYS, INC | 249-NETWORK CONTRACT OFFICE 9 | $37,915 | FY2012 |
| VA24912P1251 | DCI DONOR SERVICES, INC. | 249-NETWORK CONTRACT OFFICE 9 | $4,245 | FY2012 |
| VA24912F1002 | LABORATORY CORPORATION OF AMERICA | 249-NETWORK CONTRACT OFFICE 9 | $792,600 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24912P1289_3600_-NONE-_-NONE- · retrieved 2026-09-26.